Pentose phosphate pathway

Pentose phosphate pathway is a metabolic route operating in the cytosol of cells that oxidizes glucose-6-phosphate to generate reducing equivalents in the form of NADPH and pentose sugars such as ribose-5-phosphate. First described through biochemical studies in the 1930s and 1940s by investigators influenced by work at institutions like the Rockefeller Institute and University of Cambridge, the pathway intersects with glycolysis and contributes to biosynthetic and antioxidant defenses across taxa including Homo sapiens, Escherichia coli, and plant species studied at John Innes Centre. Key enzymes such as Glucose-6-phosphate dehydrogenase are clinically important and widely researched at centers such as Mayo Clinic and National Institutes of Health.

Overview

The pathway splits into an oxidative branch and a non-oxidative branch that together produce NADPH and sugars used for nucleotide and nucleotide sugar biosynthesis; foundational biochemical characterization occurred in laboratories affiliated with Harvard Medical School and University of Oxford. In many organisms, the oxidative phase irreversibly oxidizes glucose-6-phosphate while the non-oxidative phase interconverts three-, four-, five-, six- and seven-carbon sugars, with enzymes like Transketolase and Transaldolase originally characterized using techniques developed at Max Planck Society and Institut Pasteur. Evolutionary, the pathway is conserved from bacteria such as Bacillus subtilis to eukaryotes including yeast strains studied at California Institute of Technology.

Biochemical Pathway and Reactions

In the oxidative phase, Glucose-6-phosphate dehydrogenase catalyzes the conversion of glucose-6-phosphate to 6-phosphoglucono-δ-lactone producing NADPH; subsequent hydrolysis by 6-phosphogluconolactonase and oxidative decarboxylation by 6-phosphogluconate dehydrogenase yield ribulose-5-phosphate and additional NADPH, a sequence clarified in experiments at University of Chicago and University of Göttingen. Ribulose-5-phosphate is then isomerized by Ribulose-5-phosphate isomerase to ribose-5-phosphate or epimerized by Ribulose-5-phosphate epimerase; both enzymes’ kinetics were studied in classic enzymology labs like those at Massachusetts Institute of Technology. The non-oxidative phase employs Transketolase and Transaldolase to transfer two- and three-carbon units between sugar phosphates, linking to glycolytic intermediates fructose-6-phosphate and glyceraldehyde-3-phosphate—a metabolic integration first mapped using tracer studies at Columbia University.

Regulation and Integration with Metabolism

Regulation is largely governed by cellular NADP+/NADPH ratios and substrate availability, with Glucose-6-phosphate dehydrogenase activity subject to allosteric and transcriptional control described in reports from Stanford University and Imperial College London. Hormonal signals studied at Johns Hopkins University and University College London influence flux through interactions with insulin-responsive pathways and carbohydrate metabolism in tissues like liver and adipose, where glycolytic flux competes for glucose-6-phosphate. The reversible reactions of the non-oxidative branch allow dynamic shuttling with glycolysis and gluconeogenesis, a concept elaborated by metabolic control analyses developed at ETH Zurich and Princeton University. In plants, plastidic isoforms integrate with photosynthetic carbon flow studied at Royal Botanic Gardens, Kew.

Physiological Roles and Cellular Functions

The pathway supplies NADPH for reductive biosynthesis including fatty acid and cholesterol synthesis in hepatic tissues researched at Cleveland Clinic and supports antioxidant systems such as glutathione reductase and thioredoxin peroxidase characterized at Scripps Research Institute. Ribose-5-phosphate produced is essential for nucleotide and nucleic acid synthesis in proliferating cells, a principle exploited in oncology research at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. In erythrocytes, reliance on the pathway for maintenance of reduced glutathione links to red cell survival, a relationship examined in clinical hematology units at Guy's Hospital and Royal Free Hospital. Microbial pathogens modulate flux through the pathway during host infection, a topic of study at Wellcome Trust and Pasteur Institute.

Clinical Significance and Disorders

Inherited deficiency of Glucose-6-phosphate dehydrogenase is a common enzymopathy causing hemolytic anemia under oxidative stressors such as certain drugs, fava beans, or infections; epidemiological patterns were mapped in studies by World Health Organization and clinical cohorts at Johns Hopkins Hospital. Mutations in transketolase are linked to neurologic disorders investigated in consortia at Mount Sinai Hospital and Karolinska Institutet. Aberrant pentose phosphate pathway activity is implicated in cancer metabolism, with overexpression of pathway enzymes reported in tumor profiling studies from MD Anderson Cancer Center and targeted in therapeutic research at National Cancer Institute. Disorders of nucleotide biosynthesis and inherited metabolic diseases affecting ribose generation are evaluated in metabolic clinics associated with Boston Children's Hospital.

Category:Metabolic pathways